Clinical Research Directory
Browse clinical research sites, groups, and studies.
AIManage Using an AI-driven CDS and Chatbot
Sponsor: NYU Langone Health
Summary
The objective of this project is to define and test the GenAI-powered Clinical Decision Support (CDS) tool, AIManage, providing a broad range of incretin mimetic medication management services to optimize dose titrations. The study will take place across primary care and obesity medicine clinics at NYUH. The study is currently conducting formative data collection for tool refinement (Phase 1). Once completed, a cluster randomized controlled trial of the AIManage tool will be undertaken (Phase 2).
Official title: AIManage: Using an AI-driven CDS and Chatbot for the Management of Patients on Incretin Mimetic Medications
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
16
Start Date
2026-06-01
Completion Date
2029-03-30
Last Updated
2026-04-22
Healthy Volunteers
No
Conditions
Interventions
AIManage
GenAI-powered CDS tool that provides a range of IMM management services, such as personalized guidance for patients on side effects management and clinical advisement to optimize dose titrations.
Locations (1)
NYU Langone Health
New York, New York, United States